The metabolic syndrome

S. Novo; A. Balbarini; J. J. F. Belch; F. Bonura; D. L. Clement; E. Diamantopoulos; J. Fareed; L. Norgren; P. Poredos; K. Rotzocil

The metabolic syndrome

S. Novo, A. Balbarini, J. J. F. Belch, F. Bonura, D. L. Clement, E. Diamantopoulos, J. Fareed, L. Norgren, P. Poredos, K. Rotzocil

Research output: Contribution to journal › Review article › peer-review

16 Citations (Scopus)

Abstract

The metabolic syndrome (MetS) constitutes a major public health problem in the developed countries.(1) It is cited with different names, such as syndrome X, insulin resistance syndrome, Reaven's syndrome or CHAOS (Australia). MetS increases the cardiovascular risk, but with specific lifestyle changes and individualized drug treatment the development of serious vascular complications can be avoided.

In the last years, MetS has become a prevalent clinical condition. Therefore, it is necessary to create a complete document on the diagnosis and clinical management of MetS to avoid the confusion that derives from the vast amount of scientific papers, different revisions and definitions of the syndrome appearing in international literature during the last years.

Original language	English
Pages (from-to)	220-231
Number of pages	12
Journal	International Angiology
Volume	27
Issue number	3
Publication status	Published - 2008

Keywords

NECROSIS-FACTOR RECEPTOR
INSULIN-RESISTANCE ATHEROSCLEROSIS
NUTRITION-EXAMINATION-SURVEY
IMPAIRED GLUCOSE-TOLERANCE
TYPE-2 DIABETES-MELLITUS
RENIN-ANGIOTENSIN SYSTEM
CORONARY-HEART-DISEASE
TREATMENT PANEL-III
CARDIOVASCULAR-DISEASE
LIFE-STYLE

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{0947c852413041488700154c1b8d7dbc,

title = "The metabolic syndrome",

abstract = "The metabolic syndrome (MetS) constitutes a major public health problem in the developed countries.(1) It is cited with different names, such as syndrome X, insulin resistance syndrome, Reaven's syndrome or CHAOS (Australia). MetS increases the cardiovascular risk, but with specific lifestyle changes and individualized drug treatment the development of serious vascular complications can be avoided.In the last years, MetS has become a prevalent clinical condition. Therefore, it is necessary to create a complete document on the diagnosis and clinical management of MetS to avoid the confusion that derives from the vast amount of scientific papers, different revisions and definitions of the syndrome appearing in international literature during the last years.",

keywords = "NECROSIS-FACTOR RECEPTOR, INSULIN-RESISTANCE ATHEROSCLEROSIS, NUTRITION-EXAMINATION-SURVEY, IMPAIRED GLUCOSE-TOLERANCE, TYPE-2 DIABETES-MELLITUS, RENIN-ANGIOTENSIN SYSTEM, CORONARY-HEART-DISEASE, TREATMENT PANEL-III, CARDIOVASCULAR-DISEASE, LIFE-STYLE",

author = "S. Novo and A. Balbarini and Belch, {J. J. F.} and F. Bonura and Clement, {D. L.} and E. Diamantopoulos and J. Fareed and L. Norgren and P. Poredos and K. Rotzocil",

year = "2008",

language = "English",

volume = "27",

pages = "220--231",

journal = "International Angiology",

issn = "0392-9590",

publisher = "Edizioni Minerva Medica S.p.A.",

number = "3",

}

TY - JOUR

T1 - The metabolic syndrome

AU - Novo, S.

AU - Balbarini, A.

AU - Belch, J. J. F.

AU - Bonura, F.

AU - Clement, D. L.

AU - Diamantopoulos, E.

AU - Fareed, J.

AU - Norgren, L.

AU - Poredos, P.

AU - Rotzocil, K.

PY - 2008

Y1 - 2008

N2 - The metabolic syndrome (MetS) constitutes a major public health problem in the developed countries.(1) It is cited with different names, such as syndrome X, insulin resistance syndrome, Reaven's syndrome or CHAOS (Australia). MetS increases the cardiovascular risk, but with specific lifestyle changes and individualized drug treatment the development of serious vascular complications can be avoided.In the last years, MetS has become a prevalent clinical condition. Therefore, it is necessary to create a complete document on the diagnosis and clinical management of MetS to avoid the confusion that derives from the vast amount of scientific papers, different revisions and definitions of the syndrome appearing in international literature during the last years.

AB - The metabolic syndrome (MetS) constitutes a major public health problem in the developed countries.(1) It is cited with different names, such as syndrome X, insulin resistance syndrome, Reaven's syndrome or CHAOS (Australia). MetS increases the cardiovascular risk, but with specific lifestyle changes and individualized drug treatment the development of serious vascular complications can be avoided.In the last years, MetS has become a prevalent clinical condition. Therefore, it is necessary to create a complete document on the diagnosis and clinical management of MetS to avoid the confusion that derives from the vast amount of scientific papers, different revisions and definitions of the syndrome appearing in international literature during the last years.

KW - NECROSIS-FACTOR RECEPTOR

KW - INSULIN-RESISTANCE ATHEROSCLEROSIS

KW - NUTRITION-EXAMINATION-SURVEY

KW - IMPAIRED GLUCOSE-TOLERANCE

KW - TYPE-2 DIABETES-MELLITUS

KW - RENIN-ANGIOTENSIN SYSTEM

KW - CORONARY-HEART-DISEASE

KW - TREATMENT PANEL-III

KW - CARDIOVASCULAR-DISEASE

KW - LIFE-STYLE

M3 - Review article

SN - 0392-9590

VL - 27

SP - 220

EP - 231

JO - International Angiology

JF - International Angiology

IS - 3

ER -

The metabolic syndrome

Abstract

Keywords

UN SDGs

Fingerprint

Cite this